Valuation: Valbiotis

Market Cap 15.07M 16.96M 14.07M 12.82M 24.18M 1.63B 24.4M 170M 65.96M 834M 63.68M 62.3M 2.68B P/E 2026 *
-2.77x
P/E 2027 * -7.96x
Enterprise Value 20.77M 23.38M 19.39M 17.67M 33.32M 2.25B 33.63M 235M 90.91M 1.15B 87.77M 85.86M 3.69B EV / Sales 2026 *
6.7x
EV / Sales 2027 * 2.03x
Free-Float
97.31%
Yield 2026 *
-
Yield 2027 * -
1 day-2.00%
1 week-9.00%
Current month-7.68%
1 month-18.12%
3 months-25.06%
6 months-40.47%
Current year-8.21%
1 week 0.63
Extreme 0.634
0.73
1 month 0.63
Extreme 0.634
0.82
Current year 0.63
Extreme 0.634
1.3
1 year 0.54
Extreme 0.535
1.3
3 years 0.54
Extreme 0.535
7.5
5 years 0.54
Extreme 0.535
7.5
10 years 0.54
Extreme 0.535
10.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/03/2024
Chief Tech/Sci/R&D Officer - 01/09/2017
Director TitleAgeSince
Chairman 55 01/03/2017
Director/Board Member - 26/10/2017
Director/Board Member - 18/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
28/01/22 Others

Founder

42,480 0.4364%
28/01/22 Exercice

Founder

2,095 0.0215%
10/07/21 Exercice

Chief Technology Officer

2,000 0.0206%
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-9.00%-21.65%-89.17% 16.96M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+20.19%+81.44% 57.39B
+0.89%-0.63%+2.17%+36.19% 47.64B
+0.36%+0.81%+342.39%+742.40% 44.29B
-0.96%-4.50%+24.96%+35.38% 42.5B
-0.20%-0.77%+4.13%+105.50% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.33%+22.72% 28.53B
+0.05%-1.64%-8.14%-11.37% 24.34B
Average -0.40%-1.43%+45.21%+106.77% 39.05B
Weighted average by Cap. +0.12%-0.84%+56.95%+138.25%

Financials

2026 *2027 *
Net sales 3.1M 3.49M 2.89M 2.64M 4.97M 335M 5.02M 35.01M 13.57M 171M 13.1M 12.82M 550M 12.8M 14.41M 11.95M 10.89M 20.54M 1.38B 20.73M 145M 56.02M 708M 54.09M 52.91M 2.27B
Net income -8.2M -9.23M -7.65M -6.98M -13.16M -887M -13.28M -92.62M -35.89M -454M -34.65M -33.9M -1.46B -2.8M -3.15M -2.61M -2.38M -4.49M -303M -4.53M -31.63M -12.26M -155M -11.83M -11.58M -497M
Net Debt 5.7M 6.42M 5.32M 4.85M 9.15M 617M 9.23M 64.38M 24.95M 315M 24.09M 23.56M 1.01B 10.9M 12.27M 10.17M 9.27M 17.49M 1.18B 17.65M 123M 47.71M 603M 46.06M 45.06M 1.93B
Logo Valbiotis
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
Employees
50
Date Price Change Volume
02/10/26 €0.6370 -2.00% 63,572
01/10/26 €0.6500 -5.80% 217,004
30/09/26 €0.6900 -2.82% 149,406
29/09/26 €0.7100 -1.39% 53,612
28/09/26 €0.7200 +2.86% 70,837
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.6370EUR
Average target price
1.850EUR
Spread / Average Target
+190.42%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALVAL Stock